COVID-19 in teriflunomide-treated patients with multiple sclerosis
Amir Hadi Maghzi, Maria K. Houtchens, Paolo Preziosa, Carolina Ionete, Biljana Beretich, James Stankiewicz, Shahamat Tauhid, Ann Cabot, Idanis Berriosmorales, Tamara Schwartz, Jacob A. Sloane, Mark S. Freedman, Massimo Filippi, Howard L. Weiner, Rohit Bakshi
Topics & Concepts
TeriflunomideMultiple sclerosisMedicineCoronavirus disease 2019 (COVID-19)NeurologyPandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Neuroradiology2019-20 coronavirus outbreakChristian ministryLimitingIntensive care medicineOutbreakInternal medicineImmunologyVirologyPsychiatryFingolimodDiseaseInfectious disease (medical specialty)Mechanical engineeringTheologyPhilosophyEngineeringMultiple Sclerosis Research StudiesSARS-CoV-2 and COVID-19 ResearchPolyomavirus and related diseases